The board of directors of Beijing Tong Ren Tang Chinese Medicine Company Limited announced that with effect from 18 April 2019, Ms. Ding Yong Ling has resigned as the chief executive officer of the company as she wishes to focus on her role as chairman of the Board of the company to lead the Board to determine the strategic direction of the Group and is responsible for the high-level oversight of the management whilst continuing with her present role as an executive director, chairman of the Board, member of the Nomination Committee and member of the Remuneration Committee of the company. Ms. Ding has confirmed that she has no disagreement with the Board and there are no other matters that need to be brought to the attention of the shareholders of the Company in relation to her resignation as the chief executive officer of the company. The Board announced that Mr. Zhang Huan Ping, currently an executive director and deputy general manager of the company, has been appointed as the chief executive officer of the company with effect from 18 April 2019.